Biotecnol and PolyTherics enter into a Research Collaboration for the Development of Tribody Antibody Drug Conjugates

View

Talking about the West Midlands European Regional Development Fund Programme

View

PolyTherics expands collaboration with a top five pharmaceutical company to enhance the clinical properties of biopharmaceuticals using PolyPEG

View

Talking university spin-outs – University of Warwick

View

Psioxus Launches Phase I/II Clinical Trial Of Oncolytic Vaccine With Dosing Of Patient With Metastatic Colorectal Cancer

View

Psioxus Therapeutics converts GBP 1 million in loan notes from the Wellcome Trust

View

Mercia Fund Management congratulates PsiOxus Therapeutics on Best Biotech Fund Raiser award

View

Pro Bono Bio obtains exclusive licence from PolyTherics

View

Looking at university spin-outs: University of Birmingham

View

PolyTherics appoints new head of business development

View